Announcements Trials

Browse Landscape

Phase

Phase 2 5 Phase 1 2 Phase EARLY_PHASE1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Polycystic Ovary Syndrome 6 Squamous Cell Carcinoma of Head and Neck 2 Obesity 2 Endometrial Neoplasms 2 Breast Neoplasms 2 Urinary Bladder Neoplasms 1 Triple Negative Breast Neoplasms 1 Thoracic Neoplasms 1 Prostatic Neoplasms 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Neuroendocrine Tumors 1 Neoplasms 1 Lymphoid Interstitial Pneumonia 1 Laryngeal Diseases 1 Insulin Resistance 1 Inflammation 1 Head and Neck Squamous Cell Cancer 1 Head and Neck Neoplasms 1 Glioblastoma 1 Diabetes Mellitus 1 Barrett Esophagus 1

Interventions

Temozolomide 7 Radiotherapy 6 Bevacizumab 5 Magnetic Resonance Spectroscopy 3 ribociclib 2 olaparib 2 fluorodopa F 18 2 fluciclovine F-18 2 atezolizumab 2 abemaciclib 2 Surgical Procedures, Operative 2 Specimen Handling 2 Radiation 2 Ketoconazole 2 Everolimus 2 Disulfiram 2 Carvedilol 2 zimberelimab 1 tinostamustine 1 temsirolimus 1 senicapoc 1 sacituzumab govitecan 1 posaconazole 1 pitavastatin 1 perampanel 1 pamiparib 1 palbociclib 1 niraparib 1 mycophenolic adenine dinucleotide 1 lorlatinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase EARLY_PHASE1 × Glioblastoma × Metformin × Clear all

NCT03151772 2020-09-28

INSIDE

Sahlgrenska University Hospital

Phase EARLY_PHASE1 Terminated

Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡